Climate Drugs Medical

Baxter plans to limit stockpiling of its drugs after Hurricane Helene

US-based Baxter International Inc., is implementing an allocation policy to limit stockpiling of its drugs after Hurricane Helene ripped through its facility in.

Read More
Climate Health Pharma

Global glaciers suffer largest mass loss in 50 yrs, 2023 driest for rivers

Glaciers suffered the largest mass loss in 50 years as last year marked the driest for global rivers in 33 years, according to.

Read More
Drugs Health Medical

California state confirms two cases of bird flu, US total stands at 16 now

The US state of California has confirmed two human cases of bird flu, bringing the total number of cases in the current year.

Read More
Drugs Health Pharma

AstraZeneca’s experimental blood cancer drug gets US priority review

British-Swedish AstraZeneca’s drug for treatment of a form of blood cancer has been granted a Priority Review in the US by the drug.

Read More
Drugs Health Medical

Lilly to invest $4.5 billion to build Medicine Foundry in Indiana state, US

Eli Lilly and Company will build a $4.5 billion center for advanced manufacturing and drug development in Indiana to innovate new production methods.

Read More
Drugs Health Pharma

J&J to build $2b facility in North Carolina to make future products

 HQ Team October 2, 2024: Johnson & Johnson will invest $2 billion to build a biologics manufacturing facility in Wilson, North Carolina, anticipating.

Read More
Drugs Health Pharma

AstraZeneca, Daiichi’s Enhertu drug gets FDA’s priority review in US

AstraZeneca and Daiichi Sankyo got a priority review from the Food and Drug Administration for their Enhertu drug to treat a form of.

Read More
Drugs Health Pharma

Kezar Life Sciences halts mid-stage lupus nephritis trial after four people die

Kezar Life Sciences Inc., a US-based biotechnology company, has stopped a trial in patients with a type of kidney disease after four people.

Read More
Drugs Health Pharma

Roche arm to buy breast cancer portfolio from Regor for $850 million

Genentech, a member of the Roche Group, will acquire a portfolio of CDK inhibitors to treat breast cancer from Regor Pharmaceuticals for an.

Read More
Drugs Health Pharma

FDA faces Vanda’s ire as it rejects firm’s gastroparesis drug application

Vanda Pharmaceuticals Inc’s gastroparesis drug to treat a serious stomach condition was rejected by the Food and Drug Administration (FDA), which asked for.

Read More
X